Phibro Animal Health (PAHC) Non-Current Debt (2013 - 2026)
Phibro Animal Health (PAHC) posted Non-Current Debt of $591.8 million for Q2 2026, down 0.99% on a QoQ basis from $597.7 million in Q1 2026, and down 3.85% year-over-year from $615.4 million in Q2 2025.
Analysis
Phibro Animal Health (PAHC) Non-Current Debt (2013 - 2026) Analysis & Trends
Phibro Animal Health has reported Non-Current Debt for 14 years, with the latest figure at $591.8 million in Q2 2026.
- On a quarterly basis, Non-Current Debt fell 3.85% year-over-year to $591.8 million in Q2 2026; TTM through Jun 2026 was $591.8 million, a 3.85% decrease from a year earlier, with the FY2026 full-year figure at $591.8 million, down 3.85% from the prior year.
- Non-Current Debt was $591.8 million for Q2 2026 at Phibro Animal Health, down from $597.7 million in the prior quarter.
- The five-year high for Non-Current Debt was $622.9 million in Q4 2024, with the low at $272.9 million in Q2 2022.
- Average Non-Current Debt over 5 years is $412.0 million, with a median of $301.3 million recorded in 2023.
- The sharpest annual moves came in 2024 and 2025: Non-Current Debt decreased 9.39% in 2024, then jumped 118.02% in 2025.
- Over 5 years, Non-Current Debt stood at $276.8 million in 2022, then increased by 7.6% to $297.9 million in 2023, then soared by 109.12% to $622.9 million in 2024, then dropped by 3.09% to $603.6 million in 2025, then dropped by 1.96% to $591.8 million in 2026.
- The last three Non-Current Debt figures came in at $591.8 million (Q2 2026), $597.7 million (Q1 2026), and $603.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 299.87 Mn |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | 9.05 Bn |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | 3.85 Bn |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | 591.77 Mn |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | 8.30 Mn |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | 1.25 Mn |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 591.77 Mn |
| Mar 31, 2026 | 597.69 Mn |
| Dec 31, 2025 | 603.60 Mn |
| Sep 30, 2025 | 609.52 Mn |
| Jun 30, 2025 | 615.44 Mn |
| Mar 31, 2025 | 619.16 Mn |
| Dec 31, 2024 | 622.88 Mn |
| Sep 30, 2024 | 287.67 Mn |
| Jun 30, 2024 | 282.29 Mn |
| Mar 31, 2024 | 291.01 Mn |
| Dec 31, 2023 | 297.85 Mn |
| Sep 30, 2023 | 304.72 Mn |
| Jun 30, 2023 | 311.54 Mn |
| Mar 31, 2023 | 273.02 Mn |
| Dec 31, 2022 | 276.81 Mn |
| Sep 30, 2022 | 280.74 Mn |
| Jun 30, 2022 | 272.93 Mn |
| Mar 31, 2022 | 276.62 Mn |
| Dec 31, 2021 | 280.32 Mn |
| Sep 30, 2021 | 284.01 Mn |